Investor

Presentation

2025 H1 Report

1Rainbow Global Global Operation Manufacturing Subsidiary /

Center Base Office R&D Centers

Weifang Qingdao Ningxia 8400+ Registrations Globally

Manufacturing Bases

Spain Manufacturing Base

Jinan Global Operation Center

U.S. Houston Champaign

Manufacturing Base

Weifang Jinan R&D Centers

Weifang Process Development Center

110+ Overseas Subsidiaries

5000+ Staffs Globally

100+ Operational Countries Argentina Manufacturing Base

350+ Independent PatentsCrop Protection Industry Status

As high-cost inventories are gradually depleted The operating performance of most

irrational low-price dumping of various products has companies in the industry has shown

significantly decreased. Supported by declining recovery or significant improvement

1 supply-side costs gross margins in most with terminal YOY compared to 2024 with leading markets have now increased to reasonable levels. enterprises demonstrating clearer signs of rebound from the cyclical

trough.Overseas inventory levels remained low while global 2

demand for crop protection products returned to normal

with sustained strength. Bulk agricultural prices remain Debt default risks continue to

at median historical levels with active farmer application escalate in key crop protection

willingness and stable cultivation acreage demonstrating markets such as Brazil and

sustained inelastic demand for crop protection products. Argentina adversely impacting

China Customs data shows 17.07% YoY growth in HS business operation stability in

3 3808 export volume and 13.72% in value for Jan-Jun these regional markets.2025 indicating strong global market demand. 4

* HS: Harmonized SystemIndustry Overview

Export Volume Trends of Products Under China HS Code 3808

10k Tons

2025202420232022

35.00

30.8630.86

30.0028.62

27.24

27.4826.93

25.47

25.18

24.8624.4824.92

25.0024.06

23.11

22.3322.21

22.9920.70

21.8322.54

20.0018.9018.7521.3318.5117.9919.75

17.4319.57

18.7719.25

17.2114.4317.1014.42

15.0014.39

15.9615.41

11.95

14.6713.8213.21

12.83

10.0010.50

123456789101112

10k Tons

* H1 2025: Total export volume increased by 17.07% YoY.* Q2 2025: Total export volume increased by 22.67% YoY.* HS: Harmonized SystemIndustry Overview

Export Value Trends of Products Under China HS Code 3808

Hundred Million USD 2025 2024 2023 2022

12.00

11.35

11.0511.07

11.0010.47

9.86

10.00

9.02

8.808.79

9.00

7.887.657.79

8.007.697.647.717.717.447.157.28

6.317.26

7.006.657.506.756.66

6.327.27

6.586.816.946.656.586.076.005.425.536.416.12

5.905.82

5.005.604.945.41

4.004.59

3.00

2.00

123456789101112

* H1 2025: Total export value increases by 13.72% YoY.* Q2 2025: Total export value increased by 20.69% YoY.* HS: Harmonized SystemIndustry Overview

Export Unit Price Trends of Products Under China HS Code 3808

USD/Kg 2025 2024 2023 2022

7.00

5.976.005.85

6.005.655.58

5.355.325.485.31

5.004.934.574.564.41

4.134.17

3.88

4.003.59

3.17

2.983.043.15

3.263.273.073.08

2.872.792.92

3.002.812.97

3.033.043.14

2.872.852.852.922.962.86

2.672.692.75

2.00

1.00

-

USD/Kg 1 2 3 4 5 6 7 8 9 10 11 12

* H1 2025: Monthly average export unit price decreased from $ 2.87/kg in January to

$ 2.85/kg in June.* HS: Harmonized SystemH1 2025 Operational Review

Global Management Company Identifies

System Based on Nine Key Capability Gaps in

Core Processes Market Frontlines

* IT Initiatives: By the end of 2029 the company aims * Two Shortcomings: The 2025-2029 mid-term strategy

to achieve 100% global coverage for SAP CRM BI highlights two critical capability gaps at the market

comprehensive budgeting systems and global frontline: commercialization of key differentiated

collaboration tools. products and brand business development.* Process Optimization: By 2029 the company will fully * Strategic Realignment: Frontline teams have

implement four core business processes (DSTE MTC swiftly aligned upward with these priorities driving key

CTP PTD) and five supporting processes to enhance initiatives while dynamically aligning with corporate

operational efficiency. strategic objectives demonstrating strong execution

capabilities.

1 2H1 2025 Operational Review

Enhance Quality * Proactive Realignment of Performance Metrics Aligning with 2025-2029 mid-term strategy we

promptly recalibrated performance metrics significantly increasing weightings for operational quality

Boost Efficiency: indicators (gross margin NPAT overdue AR and long-term inventory) while drastically reducing sales

revenue's weighting.Ongoing Expansion

* Talent Strategy & Corporate Culture Confidence We maintain our established expatriate policy for

and Optimization frontline Chinese teams and enforce strict value-based selection for all key roles (Chinese

expatriates/local managers). Post-replacement of underperforming Model C subsidiary managers (2024-

of the Global 2025) performance improved markedly. Our "Commissar + Commander" model (veteran Chinese

Marketing Network expats + local leaders) now governs most Model C units demonstrating operational cultural confidence.* The company's Model C overseas subsidiaries have shown steadily improving performance over the

past five years now delivering strong and sustainable results as the global operations system matures.* Visionary Portfolio Strategy & Sustained Global Registration Investment Identifying suitable AI

ensure the successful implementation through strong and advanced technology with proper ways so

that we can have more global powerful synthesis AI to support our market development improving our

competitivity and profitability. H1 2025 delivered 600+ new approvals reaching 8400+ total global

registrations as of June 30 2025.

3H1 2025 Operational Review

Four Strategic Increased To C Business Increased EU & NA Business

Growth Pillars

TO C revenue rose from 37.52% in H1 2024 EU & North American operations increased

Operation to 40.14% in H1 2025 with gross margin from 11.42% in H1 2024 to 14.08% in H1

improving from 29.21% to 30.21% 2025.Review

Increased Insecticide & Fungicide Rainbow Bio Business

Business Acceleration

Insecticide & fungicide revenue increased Rainbow Bio has launched in multiple new

from 24.15% in H1 2024 to 26.59% in H1 countries across Africa Asia and the

2025. Americas while deepening penetration in

existing markets.

4

*EU: European Union

*NA: North AmericanFinancial Highlights

H1 2025 Financial Performance Analysis (YoY)

Currency

H1 2025 H1 2024 % Note

RMB

Sales Revenue Stable growth across all business 6530775333.21 5681756659.38 14.94%

segments.Gross Margin % YoY gross margin rate improvement for 21.42% 20.23% 1.19%

both Model A/B and Model C businesses.EBITDA 815410474.59 700234948.65 16.45%

EBITDA Profit % 12.49% 12.32% 0.17%

* Revenue growth with gross margin rate

Net Profit Attributable to enhancement

the Owner of Parent 555603360.29 181794252.02 205.62% * Increased financial expenses & hedging

gains

Net Operating Cash Flow 893182242.16 -138751214.78 743.73% Improved payment collectionFinancial Highlights

H1 2025 Financial Performance Analysis (YoY)

Currency

H1 2025 H1 2024 % Note

RMB

Higher sales expenses mainly stemmed

Selling & Distribution

Expenses 340844593.06 267719127.15 27.31%

from increased overseas payroll export

credit insurance and exhibition expenses.General & Administrative Higher administrative expenses were

Expenses 253142837.69 212412218.74 19.18% mainly due to increased overseas payroll.R&D Expenses 83428312.99 71842120.14 16.13% Primarily due to increased R&D investment.Financial Highlights

Q2 2025 Financial Performance Analysis (YoY)

Currency

Q2 2025 Q2 2024 % Note

RMB

Sales Revenue Stable growth across all business 3844489498.82 2988565060.43 28.64%

segments.Gross Margin % YoY gross margin rate improvement for 22.92% 20.34% 2.58%

both Model A/B and Model C businesses.EBITDA 537959601.08 382342060.11 40.70%

EBITDA Profit % 13.99% 12.79% 1.20%

* Revenue growth with gross margin rate

Net Profit Attributable to enhancement

the Owner of Parent 298860730.79 28950900.77 932.3% * Increased financial expenses & hedging

gains

Net Operating Cash Flow 959942509.21 159232288.32 502.86% Improved payment collectionFinancial Highlights

Q2 2025 Financial Performance Analysis (YoY)

Currency

Q2 2025 Q2 2024 % Note

RMB

Higher sales expenses mainly stemmed

Selling & Distribution from increased overseas payroll export

Expenses 179977396.99 131707000.96 36.65% credit insurance and professional service

fees.Higher administrative expenses were

General & Administrative

Expenses 126886423.26 117179271.77 8.28%

mainly due to increased professional

service fees and IT expenses.R&D Expenses 41949748.20 35755229.05 17.32% Primarily due to increased R&D investment.Financial Highlights

H1 2025 New Global Registration Status by Geographic Segment

H1 2025 New

Approvals:

600+

Brazil Latin North Europe Middle Asia (China Oceania

2.55% America America 17.83% East/Africa inclusive) 1.75%

29.62% 0.64% 16.40% 31.21%Financial Highlights

Total Global Registration Status by Geographic Segment as of June 2025

Total Approvals

8400+

Latin North Middle Asia (China

Brazil Europe Oceania

America America East/Africa inclusive)

1.98%7.33%7.20%

40.43% 0.32% 17.66% 25.08%Financial Highlights

H1 2025 Revenue Status by Geographic Segment

H1 2025 Revenue

6.531billion RMB

Latin North Middle

Brazil Asia (ChinaEurope

America America East/Africa

25.56% inclusive)

Oceania

7.60%

25.55% 8.76% 10.76% 16.40% 5.37%Financial Highlights

Revenue Share by Segment (YoY)

Revenue by Segment (H1) Quarterly Revenue by Segment

Mode C Mode C Mode C Mode C Mode C

37.52% 40.14% 37.84%Mode A + Mode A + 38.39% Mode A +

41.35%

Mode A + Mode A +

Mode B

Mode B Mode B Mode B Mode B

59.86%62.16%61.61%62.48%58.65%

H1 2024 H1 2025 Q2 2024 Q1 2025 Q2 2025Financial Highlights

Gross Margin Rate Comparison by Segment

Gross Margin Rate by Segment (H1) Quarterly Gross Margin Rate by Segment

35.00%35.00%

31.54%

30.21%

30.00%29.21%29.32%30.00%28.17%

25.00%25.00%

20.00%20.00%

16.84%

15.52%

14.83%14.88%

15.00%15.00%13.72%

10.00%10.00%

5.00%5.00%

0.00%0.00%

Mode A + Mode B Mode C Mode A + Mode B Mode C

H1 2024 H1 2025 Q2 2024 Q1 2025 Q2 2025Financial Highlights

Revenue by Product Category

Revenue by Product Category (H1) Quarterly Revenue by Product Category

Fungicide Other 1.12% Fungicide Other 1.36% Fungicide Other 1.03% Fungicide Other 1.19% Fungicide Other 1.49%

10.21%10.33%9.93%10.78%10.02%

Insecticide Insecticide Insecticide Insecticide Insecticide

13.94%16.26%13.89%16.50%16.10%

Herbicide Herbicide Herbicide Herbicide Herbicide

74.73%72.05%75.15%71.53%72.39%

H1 2024 H1 2025 Q2 2024 Q1 2025 Q2 2025Financial Highlights

Gross Margin Rate Comparison by Product Category

Gross Margin Rate by Product Category (H1) Quarterly Gross Margin Rate by Product Category

30.00%35.00%

28.18%

27.12%

24.61%30.00%29.09%

25.00%27.62%

26.91%27.25%

22.25%

25.00%

20.00%19.30%

22.50%

18.38%20.71%21.10%

20.00%18.64%

17.26%

15.00%

15.00%

10.00%

10.00%

5.00%5.00%

0.00%0.00%

Herbicide Insecticide Fungicide Herbicide Insecticide Herbicide

H1 2024 H1 2025 Q2 2024 Q1 2025 Q2 20252025 Global Crop Protection Industry Outlook

1 The crop protection industry remains at the cyclical bottom but shows initial

recovery signs: Competitive leaders with technological channel and brand

advantages demonstrate clear recovery momentum continuously

strengthening their market position.

2 Crop AIs prices softening and remain range-bound at cyclical lows.

3 Procurement Shifts Challenge Supply Chains: Channels and end-users now

favor minimal inventories delayed purchases and just-in-time buying

straining crop protection supply networks.2025 Global Crop Protection Industry Outlook

4 Products at historical price lows remain prone to sudden volatility

from disruptive events necessitating true demand-driven systems

with rapid flexible operations

5 Growers increasingly favor more cost-effective generic crop

protection products to improve profitability accelerating their market

share growth.

6 Market demand remains moderately elevated with terminal market

prices progressively normalizing to rational levels.2025 Business Outlook

Rising trade protectionism disrupts import

Terminal market prices and gross margins

1 tariffs market access exchange rates and 2 are gradually normalizing with subsidiaries commodity prices increasing operational

sustaining gross margin rate expansion.uncertainties.Expanding To C revenue share and high- Process- and IT-enabled global

3 value global registrations will drive 4 management systems drive continuous

sustained operating gross margin rate improvement in global operational quality

improvement. and capabilities.

5 2025 Targets: both revenue and shareholder net profit to grow YoYMid-Term Strategic Plan (2025-2029) - Annual Review Update

"Enhance Quality Boost Efficiency"Mid-Term Strategic Plan (2025-2029) - Annual Review Update

4 Strategic Growth Pillars

1 Increased To C Business

2 Increased EU & NA Business

3 Increased Insecticide & Fungicide Business

4 Rainbow Bio Business Acceleration

*EU: European Union

*NA: North AmericanMid-Term Strategic Plan (2025-2029) - Annual Review Update

7 Critical Tasks

1. Building up the global management system to ensure the company under healthy and safe operation.

2. Identifying important products prospectively be the first generic company to commercialize in core markets successfully.

3. Identifying suitable AI ensure the successful implementation through strong and advanced technology with proper ways so that we can have more global powerful synthesis AI to support our market development improving our competitivity and profitability.

4. Improving the formulation capabilities to be high cost-effective and efficient to support product registration quick delivery andsuccessful commercialization.

5. Continue expanding and developing global business strengthen brand building to ensure business grow in a balanced and healthy way.

6. Thoroughly understand the information from factories to farms making accurate and quick decisions developing more niche AIs andbuilding strategy aligns partners with different ways to ensure global supply chain to be safe and competitive.

7. Continuously optimizing orders’ whole processing system to ensure the high-quality cost-effective and fast delivery on schedule.Mid-Term Strategic Plan (2025-2029) - Annual Review Update

5 Key Management Capabilities

1 Global Management Capability

2 Differentiated Product Commercialization Capability

3 Brand Business Development Capability

4 High-Compatibility & Synergy-Enhanced Formulation Technology

5 Agile & Precise Global Supply ChainTo be a Global Leading Crop

Protection Company